Infectious complications in the neutropenic patient

Seminars in Pediatric Infectious Diseases

Volumn 11, Issue 2, 2000, Pages 90-96

  Jackson, Mary Anne ^a,b   Swanson, Douglas S ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S MERCY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CARBAPENEM; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; ITRACONAZOLE; PENICILLIN DERIVATIVE; TIMENTIN; VANCOMYCIN;

ALPHA HEMOLYTIC STREPTOCOCCUS; ASPERGILLOSIS; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; CANDIDIASIS; CAPNOCYTOPHAGA; CATHETER INFECTION; CHILD; CLINICAL FEATURE; CONGENITAL DISORDER; CORYNEBACTERIUM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INFECTIOUS COMPLICATION; MYCOSIS; NEUTROPENIA; REVIEW; STENOTROPHOMONAS MALTOPHILIA;

EID: 0034104267     PISSN: 10451870     EISSN: None     Source Type: Journal    
DOI: 10.1053/pi.2000.4658     Document Type: Article

References (90)

1. Hersh EM, Bodey GP, Nies BA, et al: Causes of death in acute leukemia: A ten year study of 414 patients from 1954-1963. JAMA 193:105-109, 1965
2. Bodey GP, Buckley M, Sathe YS, et al: Qualitative relationships between circulating leukocyte and infection in patients with acute leukemia. Am Jul Med 64:328-340, 1966
3. Whitecar JP Jr, Bodey GP, Luna M: Pseudamonas bacteremia in cancer patients. Am J Med Sci 260:216-223, 1970
4. Sickler EA, Greene WH, Wiernik PH: Clinical presentation of infection in granulocytopenic patients. Arch Intern Med 135:715-719, 1975
5. Schimpff S, Saterlee W, Young VM: Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and neutropenia. N Engl J Med 284:1061-1065, 1971
6. Hughes WT, Armstrong D, Bodey GP, et al: 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clin Infect Dis 25:551-573, 1997
7. Schimpff S, Scott DA, Wade JC: Infections in cancer patients: Some controversial issues. Support Care Cancer 2:94-104, 1994
8. Rahiala J, Perkkio M, Riikonen P: Infections occurring during the course of anticancer chemotherapyin children with ALL: Aretrospective analysis in 59 patients. Pediatr Hematol Oncol 15:165-174, 1998
9. Jones GR, Konsler GK, Pusek SN: Infection risk factors in febrile neutropenic children and adolescents. Pediatr Hematol Oncol 13:217-229, 1996
10. Pizzo PA, Robichaud KJ, Wesley R, et al: Fever in the pediatric and young adult patients with cancer: A prospective study of 1001 episodes. Medicine 61:163-165, 1982
11. Ingram J, Weitzman S, Greenberg ML, et al: Complications of indwelling venous access lines in the pediatric hematology patient: A prospective study of external venous catheters and subcutaneous ports. Am J Pediatr Hematol Oncol 13:130-136, 1996
12. Mackall C, Fleister T, Brown M, et al: Age thymopoesis and CD4+ T-lymphocyte regenerations after intensive chemotherapy. N Engl J Med 332:143-149, 1995
13. Van de Meer J: Defects in host defense mechanisms, in Rubin R, Young L (eds): Clinical Approach to Infections in the Compromised Host (ed 2). New York, NY, Plenium, 1994, pp 33-66
14. Lucas KG, Brown AE, Armstrong D, et al: The identification of febrile neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis. Cancer 77:791-798, 1996
15. Aquino VM, Tkaczewski I, Buchanan GR: Early discharge of low-risk febrile neutropenic children and adolescents with cancer. Clin Infect Dis 25:74-78, 1997
16. Charnas R, Ridolfi Luthi A, Ruch W: Once daily ceftriaxone plus amikacin vs three times daily ceftazidime plus amikacin for treatment of febrile neutropenic children with cancer. Pediatr Infect Dis J 16:346-353, 1997
17. Wolfson JS, Saber AJ, Rubin RH: Dermatologic manifestations of infections in the compromised host. Am Rev Med 34:205-217, 1983
18. Carey CF, Dall L: Diagnosis of cellulitis in the compromised host. Can J Infect Dis 1:133-135, 1990
19. Sloas MM, Flynn PM, Kaste SC, et al: Typhlitis in children with cancer: A 30 year experience. Clin Infect Dis 17:484-490, 1993
20. Glenn J, Cotton D, Wesley R, et al: Anorectal infections in patients with malignant diseases. Rev Infect Dis 10:42-52, 1998
21. Kavanaugh KT, Parham DM, Hughes WT, et al: Fungal sinusitis in immunocompromised children with neoplasias. Am Otol Rhinol Laryngol 100:331-336, 1991
22. Levine SJ: An approach to the diagnosis of pulmonary infections in immunosuppressed patients. Semin Respir Infect 7:81-95, 1992
23. Paganini H, Bologna R, Debbag R, et al: Fever and neutropenia in children with cancer in one pediatric hospital in Argentina. Pediatr Hematol Oncol 15:405-413, 1998
24. Awada A, van der Auwera P, Meunier F, et al: Streptococcal and enterococcal bacteremia in patients with cancer. Clin Infect Dis 15:33-48, 1992
25. Aledo A, Heller G, Ren L, et al: Septicemia and septic shock in pediatric patients: 140 consecutive cases on a pediatric hematology-oncology service. J Pediatr Hematol Oncol 20:215-221, 1998
26. Wingard JR, Merz WG, Rinaldi MG, et al: Increase in Candidakrusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 325:1274-1277, 1991
27. Warnock DW: Fungal infections in neutropenia: Current problems and chemotherapeutic control. J Antimicrob Chemother 541:95-105, 1998
28. Cotton DJ, Yolken RH, Hiemenz JW: Role of respiratory viruses in the etiology of fever occurring during chemotherapy-induced granulocytopenia. Pediatr Res 18:272A, 1984 (abstr)
29. Wood MJ: Viral infections in neutropenia: Current problems and chemotherapeutic control. Br Soc Antimicrob Chemother 41:81-93, 1998
30. Kovacs JA, Hiemenz JW, Macher AM, et al: Pneumocytis Carinii pneumonia: A comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med 100:663-671, 1984
31. Chanock SJ, Pizzo PA: Infectious complications of patients undergoing therapy for leukemia: Current status and future prospects. Semin Oncol 24:132-140, 1997
32. Walsh TJ, Hiemenz JW, Anaissie E: Recent program and current problems in treatment of invasive fungal infection in neutropenic patients. Infect Dis Clin North Am 10:365-400, 1996
33. Sotiropolous SV, Jackson MA, Woods GM, et al: Alpha streptococcal septicemia in leukemic children treated with continuous or high dosage intermittent cytosine arabinoside. Pediatr Infect Dis J 8:755-758, 1989
34. Bochud BY, Eggiman P, Calandra T, et al: Bacteremia due to viridans streptococcus in neutropenic patients with cancer: Clinical spectrum and risk factors. Clin Infect Dis 18:25-31, 1994
35. Bodey GP: The evolution of antibiotic therapy for neutropenic patients. Clin Cancer Res 3:2660-2665, 1997
36. Forlerrza SW, Newman MG, Lipsey AI, et al: Capnocytophaga sepsis a newly recognized clinical entity in granulocytopenic patients. Lancet 1:567-568, 1980
37. Roscoe DL, Zemcor JV, Thorber D, et al: Antimicrobial susceptibilities and β-lactamase characterization of Capanocytophaga species. Antimicrob Agents Chemother 36:2197-2200, 1992
38. Denton M, Kerr KG: Microbiological and clinical aspects of infection with Stenatrophamonas and Maltaphilia Clin Microbiol Rev 11:57-80, 1998
39. Elting LS, Bodey GP: Septicemia due to Xanthamonas species and non-aeruginosa Pseudomonas spp: Increasing incidence of catheter-related infection. Medicine 69:296-306, 1990
40. Navarro EE: Arcanum. Carynebacterium jeikeium Clin Infect Dis 23:1116, 1158, 1996
41. Johnson WD, Kaye D: Serious infections caused by diphtheroids. Ann N Y Acad Sci 174:568-576, 1970
42. Traub WH, Geipel V, Leonhard B, et al: Antibiotic disk susceptibility (agar disk diffusion and agar dilution) of clinical isolates of Carynebacteriumjeikeium Chemotherapy 44:230-237, 1998
43. Fosi-Mbantenkhu J, Drett FA: Predisposition to Carynebacterium jeikeium infection in acute lymphoblastic leukemia: A report of two cases in Trinidad. Med Pediatr Oncol 22:350-354, 1994
44. Van der Lelie, Leverstein-Van Hall M, Mertens M, et al: Carynebacterium CDC group JK (Carynebacteriumjekeium) sepsis in haemalological patients: A report of 3 cases and systematic literature review. Scand J Infect Dis 27:581-584, 1995
45. Reibel W, Frantz N, Adelstein D, et al: Carynebacterium JK: A cause of nosocomial device-related infection. Res Infect Dis 8:42-46, 1986
46. Raad I: Intravascular catheter-related infection. Lancet 351:893-898, 1998
47. Elishoov H, Or R, Strauss N, et al: Nosocomial colonization, septicemia, and Hickman/Broviac catheter-related infections in bone marrow transplant recipients. A 5-year prospective study. Medicine 77:83-101, 1998
48. Engelhard D, Elishoov H, Strauss N, et al: Nosocomial coagulase-negative staphylococcal infections in bone marrow transplantation recipients with central vein catheter: A 5 year prospective study. Transplantation 61:430-434, 1998
49. Costagnola E, Conte M, Venzano P, et al: Broviac catheter-related bacteraemias due to unusual pathogens in children with cancer: Case reports with literature review. J Infect 321:15-18, 1997
50. Cotton DJ, Gill VJ, Marshall DJ, et al: Clinical features and therapeutic intervention in 17 cases of Bacillus bacteremias in an immunosuppressed patient population. J Clin Microbiol 25:672-674, 1987
51. Reinert RR, Schnitzer N, Haase G, et al: Recurrent bacteremia due to Brevibacteriumcasei in an immunocompromised patient. Eur J Clin Microbiol Infect Dis 14:1082-1085, 1995
52. Conlu A, Rothman J, Staszewski H, et al: Flavimonas orzihabitans(cc group re-2) bacteremia associated with Hickman catheters. J Hosp Infect 20:293-299, 1992
53. Edmond MB, Riddler SA, Bacter CM, et al: Agrobacteriumraolobacter, a recently recognized opportunistic pathogen. Clin Infect Dis 16:388-391, 1993
54. Gerson SL, Talbot GH, Hurwitz S, et al: Prolonged granulocytopenia: The major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med 100:345-349, 1989
55. Wald A, Leisening W, van Burik JA, et al: Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 177:1775-1776, 1998
56. Jantunen E, Ruutu P, Niskanen L, et al: Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients. Bone Marrow Transplant 19:801-808, 1997
57. Kuhlman JE, Fishman EK, Siegelman SS, et al: Invasive pulmonary aspergillosis in acute leukemia: Characteristic findings on CT, the CT halo sign and the role of CT in early diagnosis. Radiologist 159:611-614, 1985
58. Verschraegen CF, van Besien KW, Dignani C, et al: Invasive Aspergillus sinusitis during bone marrow transplantation. Scand J Infect Dis 29:436-438, 1997
59. Siberry GK, Costarangos C, Cohen BA: Destruction of the nasal septum after autologous bone marrow transplantation. N Engl J Med 337:275-276, 1997
60. Khoury H, Adkins D, Miller G, et al: Resolution of invasive central nervous system aspergillosis in a transplanted recipient. Bone Marrow Transplant 20:179-180, 1997
61. Garcia-Ruiz JC, Hernandez I, Munoz F, et al: Cholangitis due to Aspergillus furrigatus in a patient with acute leukemia. Clin Infect Dis 26:228-229, 1998
62. Offner F, Cordonnier C, Ljungman P, et al: Impact of previous Aspergillosis on the outcome of bone marrow transplantation. Clin Infect Dis 26:1098-1103, 1998
63. Murphy MF, Metacalfe P, Waters AA, et al: Incidence in mechanisms of neutropenia and thrombocytopenia in patients with human immunodeficiency virus infection. Br J Haematol 66:337-340, 1987
64. Wilfert CM: Invasive bacterial infections in children with HIV infection, in Pizzo PA, Wilfert CM (eds): Pediatric AIDS: The Challenge of HIV Infection in Infants, Children, and Adolescents (ed 3). Baltimore, MD, Williams & Wilkins, 1998, pp 117-125
65. Farber BF, Lesseer M, Kaplan MH, et al: Clinical significance of neutropenia in patients with human immunodeficiency virus infection. Infect Control Hosp Epidemiol 12:429-434, 1991
66. Shaunak S, Barlett JA: Zidovudine-induced neutropenia: Are we too cautious? Lancet 2:91-92, 1989
67. Meyard JL, Guiguet M, Arsac S, et al: Frequency and risk factors of infectious complications in neutropenic patients infected with HIV. AIDS 11:995-998, 1997
68. Keiser P, Higgs E, Smith J: Neutropenia is associated with bacteremia in patients infected with the human immunodeficiency virus. Am J Med Sci 312:118-122, 1996
69. Moore RD, Keruly JC, Chaisson RE: Neutropenia and bacterial infection in acquired immunodeficiency syndrome. Arch Intern Med 155:1965-1970, 1995
70. Tumbarello M, Tacconelli E, Caponera S, et al: The impact of bacteremia on HIV infection. Nine years experience in a large Italian university hospital. J Infect 31:123-131, 1995
71. Caperna J, Barber RE, Toerner JG, et al: Estimation of the effect of neutropenia on rates of clinical bacteraemia in HIV-infected patients. Epidemiol Infect 120:71-80, 1998
72. Eng RHK, Yen K, Tecson-Tumang F, et al: Risk of gram-negative bacteremia during neutropenia in patients with AIDS. Infect Dis Clin Pract 3:373-375, 1994
73. Matthews WC, Caperna J, Toerner JG, et al: Neutropenia is a risk factor for gram-negative bacillus bacteremia in human immunodeficiency virus-infected patients: Results of a nested case-control study. Am J Epidemiol 148:1175-1183, 1998
74. Jacobson MA, Liu RC, Davies D, et al: Human immunodeficiency virus disease-related neutropenia and the risk of hospitalization for bacterial infection. Arch Intern Med 157:1825-1831, 1997
75. Kuritzkes DR, Parenti D, Ward DJ, et al: Filgrastim prevents severe neutropenia and reduces infective morbidity in patients with advanced HIV infection: Results of a randomized, multicenter, controlled trial. AIDS 12:65-74, 1998
76. Bernini JC: Diagnosis and management of chronic neutropenia during childhood. Pediatr Clin North Am 43:773-792, 1996
77. Dinauer MC: The phagocytic system and disorders of granulopoiesis and granulocyte function, in Nathan DG, Orkin SH (eds): Nathan and O ski's Hematology of Infancy and Childhood (ed 5). Philadelphia, PA, Saunders, 1998, pp 889-967
78. Jonsson OG, Buchanan GR: Chronic neutropenia during childhood. A 13-year experience in a single institution. Am J Dis Child 145:232-235, 1991
79. Lalezari P, Khorshidi M, Petrosova M: Autoimmune neutropenia in infancy. J Pediatr 109:764-769, 1986
80. Neglia JP, Watterson J, Clay M, et al: Autoimmune neutropenia of infancy and early childhood. Pediatr Hematol Oncol 10:369-376, 1993
81. Rajantie J, Kurki S, Juvonen E, et al: Prolonged pure granulocytopenia in children. Acta Paediatr 82:839-842, 1993
82. Conway LT, Clay ME, Kline WE, et al: Natural history of primary autoimmune neutropenia in infancy. Pediatrics 79:728-733, 1987
83. Bux J, Behrens G, Jaeger G, et al: Diagnosis and clinical course of autoimmune neutropenia in infancy: Analysis of 240 cases. Blood 91:181-186, 1998
84. Dale DC, Guerry D IV, Wewerka JR, et al: Chronic neutropenia. Medicine 58:128-144, 1979
85. Kostmann R: Infantile genetic agranulocytosis. Acta Paediatr Scand 45:1, 1956
86. Bonilla MA, Dale D, Zeidler C, et al: Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-methHuG-CSF) in patients with severe congenital neutropenias. Br J Haematol 88:723-730, 1994
87. Bonilla MA, Gilio AP, Ruggeriro M, et al: Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med 320:1574-1580, 1989
88. Wright DG, Kenney RF, Oette DH, et al: Contrasting effects of recombinant human granulocyte-macrophage colony-stimulating factor (CSF) and granulocyte CSF treatment on the cycling of blood elements in childhood-onset cyclic neutropenia. Blood 84:1257-1267, 1994
89. Hammond WP IV, Rice TH, Souza LM, et al: Treatment of cyclic neutropenia with granulocyte colony-stimulating factor. N Engl J Med 320:1306-1311, 1989
90. Jayabose S, Tugal O, Sandoval C, et al: Recombinant human granulocyte colony stimulating factor in cyclic neutropenia: Use of a new 3-day-a-week regimen. Am J Hematol Oncol 16:338-340, 1994